T cell abundance in blood predicts acute organ toxicity in chemoradiotherapy for head and neck cancer. - Wikidata - awgldk - TriplyDB

T cell abundance in blood predicts acute organ toxicity in chemoradiotherapy for head and neck cancer.

T cell abundance in blood predicts acute organ toxicity in chemoradiotherapy for head and neck cancer.

http://www.wikidata.org/entity/Q37662334

about

Evaluation of the efficacy of chemoradiotherapy in cervical cancer using diffusion-weighted imaging and apparent diffusion coefficient.

P2860

Q37515721-2F0C579E-ED67-4E6A-A445-69D4D7F56D72

P2860

T cell abundance in blood predicts acute organ toxicity in chemoradiotherapy for head and neck cancer.

http://www.wikidata.org/entity/Q37662334

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

T cell abundance in blood pred ...... rapy for head and neck cancer.

@en

T cell abundance in blood pred ...... rapy for head and neck cancer.

@nl

type

label

T cell abundance in blood pred ...... rapy for head and neck cancer.

@en

T cell abundance in blood pred ...... rapy for head and neck cancer.

@nl

prefLabel

T cell abundance in blood pred ...... rapy for head and neck cancer.

@en

T cell abundance in blood pred ...... rapy for head and neck cancer.

@nl

P1433

Q37662334-F73E8A48-F728-4EC0-924D-9B20110CDC1D

P1476

Q37662334-B4161AF4-99E7-47DB-B948-C2C7DDDB9E2D

P2093

Q37662334-04BBC848-926D-4052-9B2B-51A68986399D

Q37662334-252DB807-CE2F-4892-86CE-062563FA798E

Q37662334-844067E3-7DBA-4776-84A5-8D28BC738C04

Q37662334-8CB02C75-75B5-4ABA-B4E2-3A9C3F8E2435

Q37662334-900730D9-591D-494A-89F0-996941430D59

Q37662334-95886A1A-8299-4E1D-A471-00508CDC51D9

Q37662334-ABBEF975-D771-4FFA-BA0E-3874B0DBEA2F

Q37662334-ED2E3A28-46B9-4AE9-AE24-B656BC208BBE

P2860

Q37662334-09DB2A3F-23FF-4F4F-B16C-99513980A7FC

Q37662334-0DD2ED0A-2193-4803-9AAA-3A82F956EE52

Q37662334-267CA180-11EA-4B32-971B-86E178134FCD

Q37662334-32D210CF-E34B-4643-A0D2-8C4AE598773C

Q37662334-33F59A11-E546-4975-BDA0-F3AF85043F9A

Q37662334-36D65AEF-F4D5-408D-92F1-E98C35CFB203

Q37662334-460A2030-E15D-47BA-93FD-644DC1BF153E

Q37662334-4FC1A718-99D4-4E12-9EF2-E1AA075E9E8C

Q37662334-59315B6E-3F59-415F-B0EC-325F58AB2216

Q37662334-6FC524E2-B6D8-4684-B709-1565577E0C1C

P304

Q37662334-855DDE4D-7ADA-4B97-BD52-6E04FEF421CB

P31

Q37662334-7AC27429-FD78-4E1B-BECE-9A8CCF6200B8

P356

Q37662334-88C69972-7E0B-4AC6-A593-579E4B82B591

P407

Q37662334-E57E7E90-3FD6-4C5D-A2E1-7F116CDF3BA0

P433

Q37662334-979F3E55-E44B-439B-8DAD-CAA763586F60

P478

Q37662334-3F4C09E2-DC0C-4689-974D-595DA77B5CAD

P50

Q37662334-59DC26CC-9802-4D21-94D7-3573C7A80BEE

P577

Q37662334-2B48C696-5059-4FF5-A8AF-A80C4855FB45

P698

Q37662334-1D5173CB-DE3D-4502-B5DD-4ED922AACB0A

P921

Q37662334-E1308C6B-230B-4D81-8728-251372316FD9

P932

Q37662334-9493E3BA-9750-48A1-9A04-4D885826D301

P356

ONCOTARGET.11677

P1433

P1476

T cell abundance in blood pred ...... rapy for head and neck cancer.

@en

P2093

Hendrik A Wolff

http://www.w3.org/2001/XMLSchema#string

Holger M Reichardt

http://www.w3.org/2001/XMLSchema#string

L Milena Beschel

http://www.w3.org/2001/XMLSchema#string

Margret Rave-Fränk

http://www.w3.org/2001/XMLSchema#string

Markus A Schirmer

http://www.w3.org/2001/XMLSchema#string

Martin Canis

http://www.w3.org/2001/XMLSchema#string

Martin Leu

http://www.w3.org/2001/XMLSchema#string

Sybille D Reichardt

http://www.w3.org/2001/XMLSchema#string

P2860

The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity

Effect of amifostine in head and neck cancer patients treated with radiotherapy: a systematic review and meta-analysis based on randomized controlled trials

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.

The intensity of radiotherapy-elicited immune response is associated with esophageal cancer clearance.

Increased tumor necrosis factor alpha mRNA after cellular exposure to ionizing radiation

Polymorphisms in radio-responsive genes and its association with acute toxicity among head and neck cancer patients.

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.

Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy.

Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and non-oropharyngeal patients.

Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer.

P304

65902-65915

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.11677

http://www.w3.org/2001/XMLSchema#string

P407

P433

40

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Christine Stadelmann

P577

2016-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27589568

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

5323201

http://www.w3.org/2001/XMLSchema#string